Xenon Pharmaceuticals (XENE) has the following price history information. Looking back at XENE historical stock prices for the last five trading days, on April 29, 2024, XENE opened at $40.94, traded as high as $42.82 and as low as $40.60, and closed at $42.73. Trading volume was a total of 629.00K shares. On April 30, 2024, XENE opened at $42.32, traded as high as $42.71 and as low as $40.65, and closed at $40.65. Trading volume was a total of 595.90K shares. On May 01, 2024, XENE opened at $41.16, traded as high as $43.58 and as low as $41.16, and closed at $42.49. Trading volume was a total of 369.00K shares. On May 02, 2024, XENE opened at $42.80, traded as high as $43.02 and as low as $41.85, and closed at $43.00. Trading volume was a total of 204.10K shares. On May 03, 2024, XENE opened at $43.58, traded as high as $43.79 and as low as $42.84, and closed at $43.75. Trading volume was a total of 252.20K shares.

XENE Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Xenon Pharmaceuticals shares, starting with a $10,000 purchase of XENE, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	11/07/2014
End date:	05/03/2024
Start price/share:	$13.29
End price/share:	$43.75
Dividends collected/share:	$0.00
Total return:	229.19%
Average Annual Total Return:	13.38%
Starting investment:	$10,000.00
Ending investment:	$32,928.61
Years:	9.49

XENE Historical Price Range
Date	Open	High	Low	Close	Volume
04/29/2024	$40.94	$42.82	$40.60	$42.73	629.00K
04/30/2024	$42.32	$42.71	$40.65	$40.65	595.90K
05/01/2024	$41.16	$43.58	$41.16	$42.49	369.00K
05/02/2024	$42.80	$43.02	$41.85	$43.00	204.10K
05/03/2024	$43.58	$43.79	$42.84	$43.75	252.20K

About Xenon Pharmaceuticals

Xenon Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing therapeutics for patients with neurological disorders. Co.'s product pipeline of neurology-focused therapies focus on epilepsy. Co.'s product candidates include: XEN1101, a Kv7 potassium channel opener for the treatment of epilepsy and potentially other neurological disorders, such as major depressive disorder; and XEN496, a Kv7 potassium channel opener for the treatment of KCNQ2 developmental and epileptic encephalopathy. In addition, Co. has a license and collaboration agreement with Neurocrine Biosciences Inc. to develop NBI-921352, a Nav1.6 sodium channel inhibitor for the treatment of epilepsy.

XENE Historical Closing Prices
Date	Close
04/29/2024	$42.73
04/30/2024	$40.65
05/01/2024	$42.49
05/02/2024	$43.00
05/03/2024	$43.75

XENE Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.